Important information for women using oral retinoids products containing acitretin, alitretinoin and isotretinoin

Before initiating therapy the prescriber must present the female patient a risk of congenital malformations and all conditions of Pregnancy Prevention Programme.

Educational materials present below on this website are to support your discussion with a physician and a pharmacist, to remind conditions of Pregnancy Prevention Programme and to allow to document required activities related to the program.